How To Use CPT Code 95012

CPT 95012 describes the procedure for measuring the level of nitric oxide exhaled by a patient into a monitoring system. This article will cover the official description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 95012?

CPT 95012 can be used to measure the amount of nitric oxide exhaled by a patient into a monitoring system. This test is performed to check the level of inflammation in the airways of a patient who is suspected or confirmed to have an airway inflammation disease, such as bronchial asthma.

2. Official Description

The official description of CPT code 95012 is: ‘Nitric oxide expired gas determination.’

3. Procedure

1. The provider instructs the patient to inhale air that is free of nitric oxide to their maximum capacity.
2. The patient immediately exhales the air into a nitric oxide monitoring system.
3. The provider measures the amount of nitric oxide exhaled by the patient.
4. This test is performed before and after the patient starts anti-inflammatory treatment for confirmed or suspected inflammatory diseases of the airway.
5. The results of the test help the provider determine the level of inflammation in the patient’s airway and assess the patient’s response to therapy.
6. Based on the results, the provider may adjust the dose of anti-inflammatory treatment.

4. Qualifying circumstances

CPT 95012 is performed on patients who are suspected or confirmed to have airway inflammation diseases, such as bronchial asthma. The test is used to assess the level of inflammation in the patient’s airway and to evaluate the effectiveness of anti-inflammatory treatment. It is typically performed by a healthcare provider who specializes in respiratory or pulmonary care.

5. When to use CPT code 95012

CPT code 95012 should be used when measuring the level of nitric oxide exhaled by a patient into a monitoring system to assess airway inflammation. It is appropriate to use this code when performing the test before and after the patient starts anti-inflammatory treatment. However, it should not be used for other purposes or in conjunction with unrelated procedures.

6. Documentation requirements

To support a claim for CPT 95012, the healthcare provider must document the following information:

• Patient’s suspected or confirmed airway inflammation disease
• Date and time of the test
• Results of the nitric oxide measurement
• Details of any anti-inflammatory treatment the patient is receiving
• Assessment of the patient’s response to therapy
• Signature of the healthcare provider performing the test

7. Billing guidelines

When billing for CPT 95012, ensure that the test is performed by a qualified healthcare provider and that the documentation requirements are met. It is important to report this code accurately and not to report it with unrelated procedures. Additionally, be aware of any specific billing guidelines or modifiers that may apply to this code.

8. Historical information

CPT 95012 was added to the Current Procedural Terminology system on January 1, 2007. There have been no updates or changes to the code since its addition.

9. Examples

1. A patient suspected of having bronchial asthma undergoes a nitric oxide expired gas determination test to assess the level of inflammation in their airways.
2. A healthcare provider performs a nitric oxide measurement on a patient with confirmed airway inflammation to evaluate the effectiveness of their anti-inflammatory treatment.
3. A patient with suspected airway inflammation undergoes a nitric oxide expired gas determination test before and after starting anti-inflammatory therapy to monitor their response to treatment.
4. A healthcare provider measures the level of nitric oxide exhaled by a patient with bronchial asthma to determine the appropriate dosage of anti-inflammatory medication.
5. A patient with suspected airway inflammation undergoes a nitric oxide expired gas determination test to assess the severity of their condition and guide treatment decisions.
6. A healthcare provider performs a nitric oxide measurement on a patient with confirmed airway inflammation to monitor the progression of their disease and adjust their treatment plan accordingly.
7. A patient suspected of having bronchial asthma undergoes a nitric oxide expired gas determination test to evaluate the effectiveness of their current anti-inflammatory therapy.
8. A healthcare provider measures the level of nitric oxide exhaled by a patient with airway inflammation to assess their response to treatment and make necessary adjustments.
9. A patient with suspected airway inflammation undergoes a nitric oxide expired gas determination test to determine the appropriate course of anti-inflammatory treatment.
10. A healthcare provider performs a nitric oxide measurement on a patient with confirmed airway inflammation to monitor their progress and ensure their treatment plan is effective.